News | April 13, 2022
BSV to set up vaccine manufacturing facility in Genome Valley
The total investment is in the region of Rs 200 crore
The total investment is in the region of Rs 200 crore
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The peptide-based vaccine induces a t cell-dependent response
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Both companies have been selected for stand-by production by German government
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
Subscribe To Our Newsletter & Stay Updated
